 |
|
|
| |
The Pharmacokinetics, Pharmacodynamics, and Short-term Safety of Cilofexor,
a Nonsteroidal Farnesoid X Receptor Agonist, in Subjects With Hepatic Impairment
|
| |
| |
EASL 2020 Aug 27-29 virtual
Chia-Hsiang Hsueh, Andrew Billin, Shirley Li, Stephen Lin, Deqing Xiao, Chuhan Chung, Robert P. Myers, Elijah Weber, Cara Nelson - Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
